Introduction {#Sec1}
============

Arsenic is naturally occurring in various environments, from hypersaline lakes to aquifers used for drinking water and agriculture. Although many factors contribute to the presence of arsenic in water, respiratory arsenate reduction is thought to play a critical role in arsenic accumulation in anaerobic groundwater \[Reviewed in (Oremland and Stolz [@CR14]; Reyes et al. [@CR15])\]. *Shewanella* sp. ANA-3 is a model arsenate respiratory reducer that has been used in several geochemical studies aimed at understanding how arsenic is mobilized from iron oxides and into solution (Campbell et al. [@CR4]; Tufano et al. [@CR28]). Moreover, ANA-3 has also been used to investigate the genetic and biochemical mechanisms for anaerobic respiration of arsenate (Saltikov and Newman [@CR21]; Saltikov et al. [@CR23]; Murphy and Saltikov [@CR11]). Two genes, *arrA* and *arrB*, are known to be essential for anaerobic growth on arsenate and its reduction to arsenite. ArrA is a \~95 kDa molybdenum-containing arsenate reductase, and ArrB is a \~26 kDa Fe--S containing protein that interacts with ArrA. In 1997, Myers and Myers cloned and sequenced the *cymA* gene from *Shewanella oneidensis* MR-1 and showed that it was necessary for anaerobic respiration on Fe(III), nitrate, Mn(IV), and fumarate (Myers and Myers [@CR12]). Recently, *cymA*, was also shown to be critical for anaerobic arsenate respiration (Murphy and Saltikov [@CR11]). CymA is a 21 kDa cytoplasmic membrane bound tetraheme *c*-type cytochrome that is predicted to mediate electron transfer from reduced quinones to downstream electron transport components such as the periplasmic arsenate respiratory reductase (ArrAB) (Oremland and Stolz [@CR14]; Saltikov and Newman [@CR21]).

The goal of this study was to investigate the interactions between CymA and menaquinols (MQH~2~) and determine how these interactions impact arsenate respiration in *Shewanella* sp. ANA-3. We used biochemical and genetic approaches to characterize the MQH~2~-CymA interactions. Multiple sequence alignments of NrfH (tetraheme *c*-type cytochrome of nitrite reductase complex), NapC (tetraheme *c*-type cytochrome of nitrate reductase complex), and CymA, and homology modeling of CymA with the NrfAH crystal structure were also used to identify amino acid residues in CymA that might be important for MQH~2~ interactions and growth on arsenate.

Materials and methods {#Sec2}
=====================

Bacterial strains and plasmids {#Sec3}
------------------------------

Strains and plasmids used in this study are listed in Table [1](#Tab1){ref-type="table"}. The pBAD-TOPO TA expression kit (Invitrogen, CA) was used to over-express CymA. The *cymA* gene without the stop codon was cloned into the pBAD-TOPO TA vector and verified by DNA sequencing. The pBAD*cymA* plasmid was co-transformed with pEC86, containing *E. coliccm* genes, into *E. coli* TOP10 cells. The pBAD*cymA* plasmid was used to generate point mutations by site-directed mutagenesis as described later. We generated CymA point mutations used in growth curve studies using the CymA complementation vector pAN-*cymA* (Murphy and Saltikov [@CR11]). pAN*cymA-*v5-his was created by using the pBAD forward and reverse primers to generate a *cymA-*v5-his PCR product. The PCR product was then ligated into pBBR1-MCS2 to generate pAN*cymA-*v5-his.Table 1Bacterial strains and plasmids used in this studyStrain or plasmidGenotype or markers, characteristics, and usesSource or references*E. coli* strains TOPO Top 10*E. coli* host for expression; F^−^*mcrA* Δ(*mrr-hsdRMS-mcrBC*) φ80*lac*ZΔM15 Δ*lacX74 recA1 araD139* Δ(*ara-leu*)*7697galU galK rpsL* (Str^r^) *endA1 nupG*Invitrogen DH5αF^−^*endA*1 *glnV*44 *thi*-1 *recA*1 *relA*1 *gyrA*96 *deoRnupG* Φ80d*lacZ*ΔM15 Δ(*lacZYA-argF*)U169, *hsdR*17(r~K~^−^ m~K~^+^), λ--(Saltikov and Newman [@CR21]) BL21(DE3)F^−^*ompTgal dcm lon hsdS*~B~(r~B~^−^ m~B~^−^) λ(DE3 \[*lacIlacUV*5-T7 gene 1 *ind*1 *sam*7 *nin*5\])Professor Karen Ottemann, UCSC WM3064Donor strain for conjugation; *thrB*1004 *pro thi rpsL hsdS lacZ*∆M15 RP4-1360 ∆(*araBAD*)*567 ∆dapA*1341::\[*erm pir*(wt)\]W. Metcalf, Univ. Illinois; (Saltikov and Newman [@CR21])*Shewanella* strains* Shewanella* sp. ANA-3Isolated from an As-treated wooden pier piling in a brackish estuary (Eel Pond, Woods Hole, MA)(Saltikov et al. [@CR22]) AN-CYMA*Shewanella* sp. strain ANA-3; Δ*cymA*; does not respire As(V) or fumarate(Murphy and Saltikov [@CR11])Plasmids/Vectors pBBR1-MCS25.1 kb broad-host range plasmid used for complementation: Km^r^, *lacZ*(Kovach et al. [@CR9]) pAN*cymA-v5-his*5.1 kb broad-host range plasmid used for complementation: Km^r^, *lacZ* with *cymA-v5-6x his* insertThis study pBAD-TOPO-TA4.1 kb expression vector; *araC*, V5 epitope, 6x His; Amp^r^Invitrogen pBAD-*cymA*pBAD-TOPO-TA with *cymA* insertThis study pBAD-*cymA*-K91QpBAD-TOPO-TA with *cymA* K91Q insertThis study pEC86Expression vector harboring *E. coliccmABCDEFGH*, Cm^r^(Thony-Meyer et al. [@CR27]) pAN*cymA*ANA-3 *cymA* complementation vector; Km^r^(Murphy and Saltikov [@CR11]) pAN-*cymA*-K91QANA-3 *cymA* complementation vector with K91Q mutation; Km^r^This study pAN-*cymA*-K90QANA-3 *cymA* complementation vector with K90Q mutation; Km^r^This study

Preparation of CymA-enriched cytoplasmic membranes of *E. coli* {#Sec4}
---------------------------------------------------------------

A freshly transformed *E. coli* expression strain was grown in 1 L cultures (LB/Ampicillin 100 μg/mL) at 37°C and induced with 0.02% arabinose when the OD 600 nm of 0.6 was reached. After 16 h of induction at 28°C, cells were harvested and lysed by sonication in ice-cold MOPS buffer (100 mM MOPS/KOH and 5 mM EDTA, pH 7.0, 0.2 mM protease inhibitor AEBSF hydrochloride). Unbroken cells were removed by centrifugation. Crude membranes were prepared by differential centrifugation at 150,000*g* for 1.5 h at 4°C. Cytoplasmic membranes were obtained by layering the crude membranes on top of 55% (W/V) sucrose followed by ultracentrifugation at 150,000*g* for 1.5 h at 4°C. The red floating band of cytoplasmic membranes enriched with CymA was removed and further purified by repeated ultracentrifugation and resuspension of the pellet in MOPS buffer. The final CymA-enriched cytoplasmic membranes were resuspended in MOPS buffer and flash frozen in liquid nitrogen and stored at −70°C until further use (Rothery et al. [@CR20]). The heme concentration was estimated by pyridine hemochrome assay as previously described (Berry and Trumpower [@CR2]).

SDS--PAGE and heme staining {#Sec5}
---------------------------

SDS--PAGE (29:1 30% acrylamide) was used to analyze protein extracts. Gels contained 18% polyacrylamide. In-gel heme staining was done as previously described (Francis and Becker [@CR6]). Briefly, 0.2 g of *o*-dianisidine was dissolved in 20 mL of glacial acetic acid then added to 160 mL of deionized H~2~O. While dissolving the *o*-dianisidine, the SDS--PAGE gel was washed in 200 mL 12.5% TCA (trichloroacetic acid) for 30 min. The TCA wash was followed by a 30 min wash in deionized H~2~O. As the gel was being washed, 20 mL of 0.5 M sodium citrate buffer (pH 4.4) and 0.4 mL of 30% hydrogen peroxide were added to the *o*-dianisidine solution. The solution was poured over the gel while shaking until bands appeared.

Western blot {#Sec6}
------------

Western blot was performed as follows. The SDS--PAGE gel was transferred to PVDF membrane over night at 4°C and a constant 30 V. After the transfer, membranes were blocked with TBS (tris buffered saline), 5% NFDM (non-fat dry milk), and 0.1% Tween-20 for 2 h. Following the blocking, the membrane was soaked in TBS, 5% NFDM, 0.1% Tween-20 with anti-V5-HRP at 1:5,000 dilution overnight at 4°C while shaking. The next morning the blot was washed 6 × 5 min with TBS 0.1% Tween-20 followed by one 20 min wash with deionized H~2~O. The blots were developed using ECL + Plus western blotting system (Cat\# RPN 2132) from Amersham.

Fluorescence quench titration (FQT) with HOQNO {#Sec7}
----------------------------------------------

The interaction of CymA-enriched membranes with the MQH~2~ analog 2-*n*-heptyl-4-hydroxyquinoline-*N*-oxide (HOQNO) (Alexis Corp) was determined using FQT as previously described (Rothery et al. [@CR20]). The Perkin Elmer LS-50B fluorescence spectrometer was used to monitor fluorescence intensities of HOQNO with excitation and emissions wavelengths of 341 and 479 nm, respectively. All experiments were performed at room temperature (25°C) and pH 7.0 in 100 mM MOPS/KOH and 5 mM EDTA. HOQNO was incrementally added to a stirred quartz cuvette prepared in a 100 μM ethanolic solution. Protein concentrations of 0.1, 0.2, 0.3, and 0.4 mg ml^−1^ were used for each FQT experiment. The disassociation constant, *K*~d~, was determined using an equation (Eq. [1](#Equ1){ref-type=""}) that describes the fluorescence (F) of a ligand binding to an enzyme at a site as described previously (Rothery et al. [@CR20]). The equation, variable, and calculation of *K*~d~ are summarized below:$$\documentclass[12pt]{minimal}
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\begin{document}$$ \left[ {I_{\text{tot}} } \right] = \left[ {I_{\text{bound}} } \right] + \left[ {I_{\text{free}} } \right] $$\end{document}$$The specific fluorescence (F μM^−1^) of free (*f*~free~) HOQNO is determined from the linear increase in fluorescence following the FQT point. Specific fluorescence of bound HOQNO (*f*~bound~) is assumed to be zero. The concentrations (μM) of total, bound, and free inhibitor (e.g., HOQNO) correspond to \[*I*~tot~\], \[*I*~bound~\], and \[*I*~free~\], respectively. The number of HOQNO binding sites and total enzyme concentrations correspond to *n*~s~ and \[*E*~tot~\], respectively. It was assumed that one molecule of HOQNO binds to one CymA molecule. The CymA concentration (\[*E*~tot~\]) was calculated from the molar extinction coefficient of reduced minus oxidized spectra of a single *c*-type heme assumed to be \~21.84 mM^−1^ cm^−1^ at 552 nm, using UV/VIS spectroscopy (Berry and Trumpower [@CR2]; Rothery et al. [@CR20]). Lastly, *K*~d~ was calculated using known variables (\[*E*~tot~\], *n*~s~, *f*~free~, \[*I*~tot~\]) for *F*~obs~ corresponding to HOQNO at particular FQT points as described in the "[Results](#Sec12){ref-type="sec"}" section.

DMNH~2~ mediated reduction of CymA {#Sec8}
----------------------------------

DMNH~2~ reduction of CymA-enriched cytoplasmic membranes was observed by UV/VIS spectrophotometric approach. The following manipulations were done in an anaerobic glove box (N~2~ 96%, H~2~ 4%). An anaerobic 1 ml reaction was prepared in buffer \[100 mM MOPS/KOH and 5 mM EDTA (pH 7.0)\] and *E. coli* cytoplasmic membrane enriched with CymA. DMN was prepared as a 10 mM methanolic stock solution and reduced to DMNH~2~ with a 50 mM NaBH~4~ stock made in water with 0.6% NaOH. The final reaction contained 10 μM DMNH~2~. Dithionite was freshly prepared in 50 mM Tris pH 10.0 at a concentration of 500 mM. The anaerobic cuvette was plugged with a butyl rubber stopper, removed from the glove box, and immediately analyzed in the spectrophotometer (Beckman, DU650).

*Shewanella* growth curve analysis {#Sec9}
----------------------------------

Standard culturing of *Shewanella* sp. ANA-3 was performed in Luria--Bertani (LB) medium or a semi-defined medium referred to as TME (Murphy and Saltikov [@CR11]) consisting of 1.5 g L^−1^ NH~4~Cl, 0.6 g L^−1^ NaHPO~4~, 0.1 g L^−1^ KCl, 0.5 g L^−1^ yeast extract, 10 mM HEPES, 20 mM lactate, and 10 ml L^−1^ (each) trace mineral and vitamin solutions (Murphy and Saltikov [@CR11]). Anaerobic medium was prepared by boiling under a stream of N~2~ and anaerobically dispensing into N~2~-flushed Balch tubes that were sealed with butyl rubber stoppers and autoclave sterilized. Media were supplemented with 10 mM arsenate (pH 7) from sterile anaerobic stock solutions. *Shewanella* sp. ANA-3 strains were grown at 30°C, and aerobic liquid cultures were shaken at 250 rpm. Growth curves were initiated from aerobically grown cultures prepared in TME media. Various strains were inoculated into anaerobic Balch tubes at similar densities. Growth was monitored over time by measuring the OD~600 nm~ with a Spectronic 20D+.

Mutagenesis {#Sec10}
-----------

Mutations to Lys90 and Lys91 of ANA-3 *cymA* were generated based on the QuickChange Site-Directed Mutagenesis method (Stratagene). Primers AN-CymA-K90Q-F (5′- GGT CCA GTG GAT TAC TTG ATT [cag]{.ul} AAA ATC ATC G-3′), AN-CymA-K90Q-R (5′-C GAT GAT TTT [ctg]{.ul} AAT CAA GTA ATC CAC TGG ACC-3′), AN-CymA-K91Q-F (5′- CCA GTG GAT TAC TTG ATT AAG [caa]{.ul} ATC ATC GTA TCT AAA GAC- 3′), and CymA-K91Q-R (5′-GTC TTT AGA TAC GAT GAT [ttg]{.ul} CTT AAT CAA GTA ATC CAC TGG-3′) were designed with a lysine to glutamine substitution (in lowercase). The *cymA* mutagenesis reaction consisted of a 25 μL mixture containing 2.5 μL 10× *Pfu*-Turbo Hotstart Buffer (Strategene), 0.2 mM deoxynucleoside triphosphate mix, 125 ng primer, 50 ng pAN*cymA* plasmid, 1 μL *Pfu*-Turbo Hotstart DNA polymerase (Stratagene), and nuclease-free water. Samples were incubated with the following thermocycle profile: 95°C for 30 s and 18 cycles of 95°C for 30 s, 55°C for 1 min, and 68°C for 11 min. The reaction mixtures were cooled to room temperature, and 1 μL *Dpn*I (10 units) was added to each reaction mixture and incubated for 1 h at 37°C. Each reaction mixture was transformed into a DH5α strain. Plasmids were extracted and sequenced to confirm the correct mutation. The resulting K90Q- and K91Q-mutated pAN*cymA* vectors were then transformed into AN-CYMA by conjugation as previously described (Saltikov and Newman [@CR21]). The plasmid strains were denoted pAN-*cymA*-K90Q and pAN-*cymA*-K91Q, for mutations to Lys90 and Lys91, respectively.

Multiple sequence alignment and homology modeling of CymA {#Sec11}
---------------------------------------------------------

Multiple sequence alignment of *Shewanella* sp. ANA-3 CymA, *E. coli* NapC, and *Desulfovibrio vulgaris* NrfH were performed using ClustalW (Thompson 1994). PSIPRED was used to predict the secondary structure of CymA (Jones [@CR8]). The homology model of CymA based on *D. vulgaris* NrfAH crystal structure was created using SWISS-MODEL (Arnold et al. [@CR1]).

Results {#Sec12}
=======

Expression of CymA in *E. coli* {#Sec13}
-------------------------------

We used the pBAD-TOPO TA expression plasmid (Invitrogen) to over-express CymA in *E. coli*. This plasmid features an [l]{.smallcaps}-arabinose inducible promoter, a V5 epitope, and 6× His-tag fused to the C-terminus of the expressed protein. Previous studies have shown that over-expression of multiheme *c*-type cytochromes in *E. coli* required simultaneous over-expression of cytochrome maturation genes (Thony-Meyer et al. [@CR27]). CymA-enriched membranes were prepared in an *E. coli* host co-transformed with pBAD*cymA* (and *cymA* alleles) and pEC86; the latter plasmid constitutively expresses the *E. coli* cytochrome maturation genes. Based on the hemochrome pyridine analysis, 1 mg mL^−1^ of cytoplasmic membrane yielded 12.5 μM of CymA. While 0.1 μg of cytoplasmic membrane preparation was sufficient for western blot detection of CymA (wild-type and *cymA* alleles), 10 μg was needed to detect CymA expressed without hemes (in *E. coli* lacking the *ccm* plasmid). We speculated that this was due to degradation of CymA apo-protein. Heme staining confirmed the lack of heme detection in extracts prepared from *E. coli* without pEC86 (Fig. [1](#Fig1){ref-type="fig"}). These results are consistent with previous work showing that an *E. coli* Δ*ccmABCDEFGH* mutant failed to synthesize mature cytochrome *c* (Thony-Meyer et al. [@CR27]). Furthermore, we showed that CymA fused to the V5 epitope, and the 6× His-tag (pAN*cymA*-v5-his) was capable of complementing the growth of ANA-3 Δ*cymA* strain on arsenate (Fig. S1A), indicating that the modified CymA protein still functions normally in respiratory arsenate reduction. CymA-K91Q-enriched membranes were expressed, purified, and stored similar to wild type.Fig. 1CymA expression. *Top panel* western blot analysis. *Bottom panel* heme stain. Lanes correspond to *1*, membrane only; *2*, CymA − *ccm*; *3*, CymA + *ccm*.; and *4*, CymA K91Q + *ccm*. All samples are cytoplasmic membrane fractions. The western blot analysis contained 0.1 μg protein per lane, except for CymA − *ccm*, which contained 10 μg of protein. All heme stain samples were loaded at 50 μg of protein per lane

Homology model of CymA and prediction of key amino acids {#Sec14}
--------------------------------------------------------

To predict a homology model of CymA, ClustalW was first used to perform a multiple sequence alignment of the primary amino acid sequence of *E. coli* NapC, the tetraheme subunit of nitrate reductase (EcNapC), *Desulfovibrio vulgaris* NrfH, the tetraheme subunit of nitrite reductase (DvNrfH), and CymA (ANA3CYMA) (Fig. [2](#Fig2){ref-type="fig"}a) (Thompson et al. [@CR26]). PSIPRED was then used to predict the secondary structure of CymA, which is presented above the alignment (Fig. [2](#Fig2){ref-type="fig"}a). Finally, Swiss-Model was used to predict a homology model of CymA based on the structure of DvNrfAH (PDB ID: 2J7A), nitrite reductase (Fig. [2](#Fig2){ref-type="fig"}b) (Arnold et al. [@CR1]). Using the multiple sequence alignments, homology model (Fig. [2](#Fig2){ref-type="fig"}), and other reports, we predicted that Lys91 of CymA would be important for interacting with menaquinol-like substrates (Rodrigues et al. [@CR16]). Lys91 is located in the putative second helix of CymA, which is proposed to interface with the cytoplasmic membrane and periplasmic space (Fig. [2](#Fig2){ref-type="fig"}b) (Rodrigues et al. [@CR16]).Fig. 2NapC, NrfH, and CymA multisequence alignment and homology model of CymA to DvNrfH, tetraheme cytochrome subunit of nitrite reductase NrfAH. **a** The primary amino acid sequences of *Shewanella* sp. ANA-3 CymA (AnaCymA, Shewana3_3977, Genbank accession YP_871601), *E. coli* nitrate reductase (EcNapC, Genbank accession NP_416706), and *Desulfovibrio vulgaris* nitrite reductase (DvNrfH, Genbank accession YP_009846) were aligned using ClustalW. PSIPRED (<http://bioinf.cs.ucl.ac.uk/psipred/psiform.html>) was used to predict CymA secondary structure, which is presented above the alignment (Pred); *C*, *H*, and *E* indicate coil, helix, and strand, respectively. *Helix 1* and *2* are indicated above the alignment by *H1* and *H2*, respectively. The Lys residues involved in putative menaquinol binding and oxidation are highlighted with *black boxes*. The *c*-type heme binding motifs, CXXCH, are *underlined*. **b** Homology model of CymA and highlighted residues predicted to be involved in CymA-menaquinol interaction and MQH~2~ oxidation. *H1* and *H2* indicate the first and second helix of CymA, respectively. Swiss Modeler was used to predict the structure of CymA using DvNrfAH (PDB ID: 2J7A) as a template

HOQNO interactions with CymA-enriched membranes {#Sec15}
-----------------------------------------------

MQH~2~-CymA interactions were investigated indirectly by fluorescence quench titration (FQT) with HOQNO, a fluorescent MQH~2~ structural analog. FQT with HOQNO has been used to characterize quinol binding to membrane subunits of the fumarate and DMSO reductases (Rothery and Weiner [@CR19]; Rothery et al. [@CR20]). When titrating HOQNO into a sample containing an interacting partner, fluorescence quenching should be observed until all the binding sites become saturated. After the fluorescence quench titration point, continued HOQNO additions typically yield a linear increase in fluorescence reflecting free HOQNO. When applying FQT to CymA-enriched cytoplasmic membranes, compared to membranes without CymA (Fig. [3](#Fig3){ref-type="fig"}a), we observed dramatic fluorescent quenching with membranes enriched with CymA (Fig. [3](#Fig3){ref-type="fig"}b). Using Eqs. [1](#Equ1){ref-type=""}--[3](#Equ3){ref-type=""} (Rothery et al. [@CR20]), we estimated the HOQNO disassociation constant (*K*~d~,) for CymA to be 0.1--1.0 μM. We could not determine whether CymA over-expressed without pEC86 interacted with HOQNO because of the low CymA content in these membrane preparations (100 fold less than membranes expressed with pEC86).Fig. 3Fluorescence quench titration (FQT) of *E. coli* cytoplasmic membrane fractions. The experiment was performed at room temperature, and HOQNO was added from a 10 mM ethanolic solution. **a** Membrane only **b** CymA + *ccm***c** CymA K91Q + *ccm*, and **d** comparison of (*filled square*) 0.2 mg mL^−1^ and (*filled triangle*) 0.3 mg mL^−1^ FQT curves of CymA K91Q + *ccm* and (*open square*) 0.2 mg mL^−1^ and (*open triangle*) 0.3 mg mL^−1^ wild-type CymA + *ccm.* Each sample was assayed at three different protein concentrations: (*filled circle*) 0.1 mg mL^−1^, (*filled square*) 0.2 mg mL^−1^, and (*filled triangle*) 0.3 mg ml^−1^. CymA + *ccm* was further assayed at (*filled diamond*) 0.4 mg mL^−1^. 1 mg ml^−1^ of cytoplasmic membranes corresponded to 12.5 μM CymA. Plots are representatives of three independent FQT experiments. Note that the *Y*-axis scale changes in *panel A through D*

The role of CymA Lys91 in HOQNO interactions {#Sec16}
--------------------------------------------

To investigate the role of Lys91, we substituted this site with Gln (K91Q) and over-expressed the mutant allele (called *cymA*-K91Q) in *E. coli*. FQT response (Fig. [3](#Fig3){ref-type="fig"}c) for CymA-K91Q was linear indicating weak interactions with HOQNO. A representative western and in-gel heme stain of cytoplasmic membranes enriched with CymA-K91Q are shown in Fig. [1](#Fig1){ref-type="fig"}. Semi-quantitative western blot with densitometry showed that the CymA-K91Q expression in the membrane preparation was \~75% of those containing wild-type CymA (data not shown). Because the CymA-K91Q expression was \~25% less than that of the wild type, the decreased HOQNO quenching that was observed in Fig. [3](#Fig3){ref-type="fig"}c could be due to less CymA and not the mutation. A closer inspection of the 0--0.5 μM HOQNO FQT curves of wild-type CymA and CymA-K91Q (Fig. [3](#Fig3){ref-type="fig"}d) showed a linear increase in fluorescence (and no quenching) with CymA-K91Q-enriched membranes for 0.2 mg mL^−1^ and 0.3 mg mL^−1^ protein concentrations. In contrast, significant fluorescence quenching compared to CymA-K91Q was observed for wild-type CymA-enriched membranes. Moreover, fluorescence quenching of the wild-type CymA increased with increasing protein concentration unlike CymA-K91Q. This comparison indicated that the decreased HOQNO quenching in CymA-K91Q is most likely due to the amino acid substitution and not due to the 25% decrease in protein expression relative to the wild type. Based on these observations, we concluded that substituting Lys91 with an uncharged amino acid such as Gln disrupted quinol interactions.

Reduction of CymA with DMNH~2~ {#Sec17}
------------------------------

We were interested in determining whether CymA interactions with MQH~2~ substrates could lead to heme reduction. This was investigated by using DMNH~2~, a redox active structural analog of menaquinol, as a relevant physiological reductant for CymA. For cytochromes like CymA, their oxidation and reduction can be monitored in membrane preparations by observing redox-induced changes in specific absorption peaks such as the Soret band (410 nm shifts to 420 nm) and the appearance of α- (552 nm) and β-bands (525 nm). Figure [4](#Fig4){ref-type="fig"} shows difference spectra of air-oxidized minus reduced CymA-enriched cytoplasmic membranes with several different reductants: NaBH~4~, DMNH~2~ (DMN reduced with NaBH~4~), and sodium dithionite; all three could reduce CymA, however, with dramatically varying degrees of efficiency. Membranes without CymA reduced with DMNH~2~, dithionite, and NaBH~4~ showed no noticeable changes in Soret, α-, and β-bands (data not shown). Table [2](#Tab2){ref-type="table"} shows the estimated amount of heme reduced with the three different reductants. Dithionite alone reduced the most heme, \~655 pmol compared to DMNH~2~ (165 pmol) (Table [2](#Tab2){ref-type="table"}). The same amount of NaBH~4~ used in preparing the DMNH~2~ stock reduced only \~32 pmol heme. The greater reduction of CymA by dithionite relative to DMNH~2~ is likely due to differences in their redox potentials \[−660 and −75 mV, respectively (Lancaster et al. [@CR10])\] and how these reductants interact with CymA. Dithionite is predicted to directly reduce the heme groups of CymA. However, DMNH~2~-dependent reduction of CymA most likely occurs at the Q-site, which is located in helix 2 (Fig. [2](#Fig2){ref-type="fig"}). Moreover, DMNH~2~ lacks a lipophilic carbon tail (unlike endogenous menaquinols). These factors likely led to the decreased efficiency of DMNH~2~-dependent reduction of CymA relative to dithionite. Despite these observations, we concluded that CymA could be reduced by a redox active MQH~2~ analog.Fig. 4Reduced minus air-oxidized spectra of *E. coli* cytoplasmic membrane enriched with CymA (*solid curves*) or CymA-K91Q (*dashed curves*). **a** The *two larger peaks* represent the membranes reduced with DMNH~2~. The *two smaller peaks* (indicated by an *arrow*) represent membranes reduced with only NaBH~4~. **b** Dithionite-reduced membranes. The spectra are representative spectra from three different experimentsTable 2Physiology and menaquinol-binding properties of CymAStrainGrowth on As(V)^*a*^Dithionite heme reduction (pmol)NaBH~4~ heme reduction (pmol)DMNH~2~ heme reduction (pmol)*K*~d~ (μM)Wild type+655321650.1--1.0K91Q−6273787−K90Q+NDNDNDND*ND* Not determined^a^ + and − refer to growth or no growth, respectively

DMNH~2~-dependent reduction of CymA-K91Q {#Sec18}
----------------------------------------

Cytoplasmic membranes enriched with CymA-K91Q showed similar reduction patterns with dithionite (627 pmol) and NaBH~4~ (37 pmol) (Table [2](#Tab2){ref-type="table"}). However, DMNH~2~-dependent heme reduction was diminished by 50% (87 pmol) in CymA-K91Q-enriched cytoplasmic membranes compared to those of wild-type CymA (165 pmol). These reactions were carried out with similar heme content determined through pyridine hemochrome analysis. Moreover, the dithionite-reduced spectra of cytoplasmic membrane preparations for both CymA and CymA-K91Q were indistinguishable (Fig. [4](#Fig4){ref-type="fig"}b) also suggesting that the heme content in both reactions was the same and could be reduced by the same amount. Therefore, the diminished 552 nm absorption peak for DMNH~2~-reduced CymA-K91Q (Fig. [4](#Fig4){ref-type="fig"}a) is most likely attributed to the alterations in MQH~2~ binding site of CymA-K91Q. Lys91 is likely to be important for MQH~2~-dependent reduction of CymA.

Physiology of CymA Q-site mutations in *Shewanella* sp. ANA-3 {#Sec19}
-------------------------------------------------------------

Though we have shown that *E. coli* cytoplasmic membrane fractions expressing CymA-K91Q did not quench HOQNO fluorescence and had diminished capabilities of being reduced with DMNH~2~, we wanted to investigate the physiological effects of the *cymA*-K91Q allele in *Shewanella* sp. ANA-3 ∆*cymA* strain. From an earlier investigation of the role of *cymA* in arsenate respiration, we could complement a Δ*cymA* strain with a plasmid containing the wild-type *cymA* allele (pAN-*cymA*) (Murphy and Saltikov [@CR11]). Using pAN-*cymA* as a template for site-directed mutagenesis, we introduced K91Q into *cymA* to generate the plasmid pAN-*cymA*-K91Q. Anaerobic arsenate growth curves were generated with *Shewanella* sp. ANA-3 ∆*cymA* strains harboring the pAN-*cymA* or pAN-*cymA*-K91Q plasmids (Fig. [5](#Fig5){ref-type="fig"}). The *cymA*-K91Q allele failed to complement the Δ*cymA* strain grown on arsenate. Furthermore, the *cymA*-K91Q allele also failed to complement the Δ*cymA* strain when grown on fumarate (Fig. S1B) and on Fe(III) citrate (data not shown). In addition to K91Q, we also considered Lys90 because of its close proximity to Lys91 (Fig. [2](#Fig2){ref-type="fig"}). A *Shewanella* sp. ANA-3 ∆*cymA* strain with *cymA*-K90Q allele was generated from pAN-*cymA*. Unlike K91Q, the *cymA*-K90Q allele was able to complement the ∆*cymA* ANA-3 strain similar to wild type (data not shown). This result suggests that Lys90 may not be important in menaquinol interaction, unlike Lys91.Fig. 5Growth curve analysis of *Shewanella* sp. strain ANA-3 grown anaerobically with 20 mM lactate and 10 mM arsenate. Symbols represent: *filled circle* wild type, *open circle* Δ*cymA*, *open square* Δ*cymA* with vector pBBR1-MCS2, *filled diamond* Δ*cymA* with complementation vector pAN-*cymA*, and *open diamond* Δ*cymA* with complementation vector pAN-*cymA-*K91Q. *Data points* and *error bars* represent averages and standard deviations of triplicate cultures, respectively

Discussion {#Sec20}
==========

The aim of this study was to investigate the interactions between CymA and MQH~2~ in arsenate respiration. To investigate this interaction, we used MQH~2~ structural analogs 2-*n*-heptyl-4-hydroxyquinoline-*N*-oxide (HOQNO) and the redox active analog 2,3-dimethoxy-1,4-naphthoquinone(ol) (DMN(H~2~)). Although HOQNO is a well-known respiratory inhibitor, the use of FQT with HOQNO has not been applied before to understanding quinone interactions with NapC/NrfH-like tetraheme cytochromes. Using this technique, we showed that *E. coli* membranes enriched in CymA interacted with HOQNO with an estimated *K*~d~ of 0.1--1 μM. In membranes lacking CymA, we observed a linear increase in fluorescence of HOQNO (Fig. [3](#Fig3){ref-type="fig"}a), indicating that HOQNO interaction with endogenous partners in the membranes was weak or minimal. From this observation, we concluded that the increased quenching observed in Fig. [3](#Fig3){ref-type="fig"}b is due to the presence of CymA in the membrane. In comparison, Brandt and Jagow ([@CR3]) used FQT to show that bovine mitochondrial cytochrome *c* reductase (Complex III) interacted with HOQNO with a *K*~d~ close to 50 nM for both reduced and oxidized reductases (Brandt and von Jagow [@CR3]). Other uses of FQT and HOQNO included bacterial respiratory complexes such as the *E. coli* fumarate and DMSO reductases, which have shown to exhibit strong interactions with HOQNO, *K*~d~ of 2.5 and 7.1 nM, respectively (Geijer and Weiner [@CR7]; Rothery et al. [@CR20]). These data were also determined using membrane preparations expressing complete oxidoreductases DmsABC or FrdABCD and not purified protein. It is possible that HOQNO-CymA interactions would be greater when CymA is expressed as a complex with a terminal reductase such as arsenate respiratory reductase (e.g., ArrAB in *Shewanella*).

Because HOQNO is non-redox active, we used the redox active menaquinol analog DMNH~2~ to show that CymA can be reduced by a model MQH~2~ substrate (Fig. [4](#Fig4){ref-type="fig"}). Similarly to HOQNO, DMNH~2~ has been used to probe the redox properties of DmsABC and FrdABCD, for example (Geijer and Weiner [@CR7]). Our observations provide a basis to test the hypothesis that CymA functions as a quinol-oxidase that can reduce ArrAB. Further biochemical investigations will be required to determine the kinetic properties of reduction and oxidation when CymA is part of a terminal reductase complex.

Based on multiple sequence alignments with NrfH and protein structure modeling, we identified a lysine residue (Lys91) in the second helix of CymA that is predicted to be important for binding MQH~2~ (Fig. [2](#Fig2){ref-type="fig"}b). Changing Lys91 (a positively charged residue) to Gln (a polar, uncharged group with similar side chain length) disrupted CymA interactions with MQH~2~ substrates. Through FQT with HOQNO and MQH~2~-CymA reduction experiments, we showed that the CymA-K91Q MQH~2~ interactions and heme reduction were significantly diminished (Figs. [3](#Fig3){ref-type="fig"}, [4](#Fig4){ref-type="fig"}). A *K*~d~ for HOQNO with CymA-K91Q could not be determined because of the nearly linear response of HOQNO titration into membrane preparations enriched in CymA-K91Q. The critical role of Lys91 in MQH~2~-CymA interaction is supported by molecular modeling of the *D. vulgaris* NrfH docked with HOQNO showing that Lys82 (Lys91 in CymA) forms an H-bond with the *N*-oxide (replacing one of the carbonyl groups) of HOQNO, helping to keep it in place (Rodrigues et al. [@CR16]; [@CR17]). The K91Q alteration in CymA most likely disrupted one of the H-bonds necessary for the interaction of HOQNO with CymA, resulting in weakened interaction with HOQNO and the near linear FQT response (Fig. [3](#Fig3){ref-type="fig"}c). The lack of growth on arsenate (fumarate and Fe(III) citrate) for pAN-*cymA*-K91Q (Fig. [5](#Fig5){ref-type="fig"}, Fig. S1B) provides further evidence in support of Lys91 as a critical residue for MQH~2~ oxidation and heme reduction of CymA. We also investigated Lys90 because of its close proximity to Lys91. Neither NrfH nor NapC has this second proximal Lys residue. Growth curve analysis of *cymA*-K90Q allele in *Shewanella* sp. ANA-3 ∆*cymA* strain was indistinguishable from the wild type indicating that Lys90 might not be important for MQH~2~ interaction. Based on the CymA homology model, there are likely other amino acid residues in CymA that are involved in MQH~2~ interactions and heme reduction (Fig. [2](#Fig2){ref-type="fig"}b, e.g., K96, D97).

The homology model of CymA (Fig. [2](#Fig2){ref-type="fig"}b) indicates that helix 2 (H2) amino acid residues might be responsible for the interaction with menaquinol. Schwalb et al*.* ([@CR25]) provided biological evidence that a soluble form of CymA (missing the first 35 amino acids comprising the N-terminal helix, helix 1) was functional because it could reduce the soluble fumarate reductase flavocytochrome FccA (Schwalb et al. [@CR25]). Furthermore, it was shown that the soluble version of CymA could complement a *cymA* disruption mutant in MR-1. This indicated that even though the membrane-anchoring helix (H1) could be removed, CymA might still have the capacity to associate with the cytoplasmic membrane through the second helix, and that H2 amino acid residues might be sufficient for menaquinol interaction and oxidation.

Our data support the hypothesis that CymA is the electron mediator between the menaquinol pool and the arsenate respiratory reductase (ArrAB). Because CymA has four low-spin hemes with redox potentials of +10, −108, −136, and −229 mV, menaquinols (*E*~o~′ −74 mV) would be preferred over ubiquinols (*E*~*o*~′ +112 mV) (Field et al. [@CR5]) as reductants for arsenate reduction (electrochemical potential *E*~o~′ As(III)/As(V) = +139 mV). Furthermore, CymA shares homology with other NapC/NrfH *c*-type tetraheme cytochromes in that a lysine residue on the second helix is important for menaquinol interaction, electron transfer, and/or possibly proton translocation (Roldan et al. [@CR18]). Lastly, in *Shewanella* (ANA-3 and other strains), CymA has an interesting physiological function because it acts as a major branching point to other electron transport chains including arsenate, DMSO, fumarate, nitrate, nitrite, vanadate, and oxides of Fe(III) and Mn(IV) (Myers and Myers [@CR12]; Schwalb et al. [@CR24]; Myers et al. [@CR13]; Murphy and Saltikov [@CR11]). Compared to the nitrite reductase complex of *D. vulgaris*, which consists of NrfA (α) and NrfH (β) in a α~4~β~2~ configuration, it is still unclear whether CymA forms a multimeric complex with itself or other proteins (Rodrigues et al. [@CR16]). Further investigations of the interaction of CymA and ArrAB will be insightful for understanding the details of the electron transport chain leading to arsenate reduction and other electron acceptors in *Shewanella* species.
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